Overview
- 5 public-safe observations are available for this inspection.
- 3 structured CFR citations are represented.
- 3 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
Tissue residue
Cited by Christian L Witkovskie, Tracey L Harris, Matthew J Zagula
Drug inventory
Cited by Christian L Witkovskie, Tracey L Harris, Matthew J Zagula
Record keeping
Cited by Christian L Witkovskie, Tracey L Harris, Matthew J Zagula
Records review prior to slaughter
Cited by Christian L Witkovskie, Tracey L Harris, Matthew J Zagula
Expired drugs
Cited by Christian L Witkovskie, Tracey L Harris, Matthew J Zagula
Inspected site
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| FDCA 402(a)(4) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 530.11(d) | Cited across public-safe Form 483 observations | 1x |
| FDCA 501(a)(5) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 5 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere